1 The aim of this study was to functionally characterize the recombinant mouse P2X 4 receptor and to compare its pharmacological properties with those of the human and rat orthologues. 2 Whole cell recordings were made from rafts of HEK-293 cells stably expressing recombinant mouse, rat or human P2X 4 receptors, using Cs-aspartate containing electrodes (3 ± 8 MO) in a HEPES-buered extracellular medium. 3 The agonist potency of ATP at the three species orthologues was similar, with mean EC 50 values of 2.3 mM, 1.4 mM and 5.5 mM, respectively. 4 Adenosine-5'-tetraphosphate (AP4) acted as a partial agonist with respect to ATP at the mouse and human P2X 4 receptors (EC 50 =2.6 and 3.0 mM), but was signi®cantly less potent at the rat orthologue (EC 50 =20.0 mM). a,b-methylene adenosine-5'-triphosphate (a,b-meATP) also acted as a partial agonist, producing 29% of the maximum response at the mouse P2X 4 and 24% at the human P2X 4 receptor. 5 In contrast to the other species orthologues, a,b-meATP failed to elicit a signi®cant agonist response at rat P2X 4 receptors, and was found to act as an antagonist, with an IC 50 of 4.6 mM, against 10 mM ATP. 6 Mouse P2X 4 receptors were found to be sensitive to the antagonist, pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) (IC 50 =10.5 mM), as were human P2X 4 receptors (IC 50 =9.6 mM). The rat receptor however, showed a low sensitivity to PPADS (IC 50 4100 mM). 7 All three orthologues were relatively suramin-insensitive (IC 50 4100 mM) and insensitive to 1-[N,O-Bis(5-isoquinoline sulphonyl)benzyl]-2-(4-phenylpiperazine)ethyl]-5-isoquinoline sulphonamide (KN-62; IC 50 43 mM). 8 Our results suggest that the pharmacological properties of the mouse receptor are most similar to the human P2X 4 receptor, and dier markedly from the rat receptor.